COLLAGÈNE+ ETERNITY
Food supplement declared in France, decision dated 28 October 2026
COLLAGÈNE+ ETERNITY (GRANIONS) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- GRANIONS
- Food business operator placing the product on the market
- EQUILIBRE ATTITUDE
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Tablet
- Daily dose
- 3 comprimés
- Directions for use
- Prendre 3 comprimés par jour avec un grand verre d’eau, de préférence le matin, avant le repas
- Intended populations
- General population
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Children (under 6), Children (under 10)
- Objectives stated by the manufacturer (these are not authorised claims)
- Peau, Autre : Beauté - Anti-âge
Declaration 372646, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Malpighia glabra L. | Fruit | Extrait sec aqueux | 112 mg |
| Hibiscus sabdariffa L. | Fleur | Extrait sec aqueux | 50 mg |
| Lycopersicon esculentum Mill. | Fruit | Extrait sec aqueux | 32 mg |
| Beta vulgaris L. | Racine | Extrait sec aqueux | 32 mg |
| Helichrysum italicum (Roth.) G. Don. | Fleur | Extrait sec hydroalcoolique | 30 mg |
| Vitis vinifera L. | Feuille | Extrait sec aqueux | 15 mg |
| Malus domestica Borkh | Fruit | Extrait sec aqueux | 12 mg |
| Vitis vinifera L. | Fruit | Extrait sec aqueux | 2 mg |
| Malpighia glabra L. | Fruit | Extrait sec aqueux | 1 mg |
| Euterpe oleracea Mart. | Fruit | Extrait sec aqueux | 1 mg |
| Aronia melanocarpa (michx.) Elliot | Fruit | Extrait sec aqueux | 1 mg |
| Musa × paradisiaca L. | Fruit | Extrait sec aqueux | 1 mg |
| Citrus limon (L.) Burm. f. | Fruit | Extrait sec aqueux | 1 mg |
| Ribes nigrum L. | Fruit | Extrait sec aqueux | 1 mg |
| Vaccinium myrtillus L. | Fruit | Extrait sec aqueux | 1 mg |
| Vaccinium oxycoccos L. | Fruit | Extrait sec aqueux | 1 mg |
| Citrus aurantiifolia (Christm.) Swingle | Fruit | Extrait sec aqueux | 1 mg |
| Ribes rubrum L. | Fruit | Extrait sec aqueux | 1 mg |
| Actinidia chinensis Planch. | Fruit | Extrait sec aqueux | 1 mg |
| Citrus paradisi Macfad. | Fruit | Extrait sec aqueux | 1 mg |
| Prunus domestica L. | Fruit | Extrait sec aqueux | 1 mg |
| Prunus persica (L.) Stokes | Fruit | Extrait sec aqueux | 1 mg |
| Pyrus communis L. | Fruit | Extrait sec aqueux | 1 mg |
| Ananas comosus (L.) Merrill | Fruit | Extrait sec aqueux | 1 mg |
| Punica granatum L. | Fruit | Extrait sec aqueux | 1 mg |
| Rubus idaeus L. | Fruit | Extrait sec aqueux | 1 mg |
| Fragaria × ananassa (Duchesne ex Weston) Duchesne ex Rozier | Fruit | Extrait sec aqueux | 1 mg |
| Prunus avium (L.) L. | Fruit | Extrait sec aqueux | 1 mg |
| Mangifera indica L. | Fruit | Extrait sec aqueux | 1 mg |
Substances
| Name | Per day |
|---|---|
| proline | 100 mg |
| glycine | 100 mg |
| glutathion | 100 mg |
| resvératrol | 25 mg |
| nicotinamide adénine dinucléotide réduite | 10 mg |
| céramides | 5 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Ubiquinone | not declared |
| Hydroxyproline | not declared |
| Hyaluronate de sodium | not declared |
| Hydrolysat de collagène de poisson | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| D-biotine | Biotine (vitamine B8) | pas de limite (données insuffisantes) | dose annulled by the French Council of State in 2011 |
| Nicotinamide | Nicotinamide (vitamine B3) | 900 mg | 54 mg |
| Chlorure de nicotinamide riboside | Nicotinamide (vitamine B3) | 900 mg | 54 mg |
| Acétate de rétinyle | Vitamine A | 3,000 µg d'équivalent rétinol | 800 µg |
| Acétate de DL-alpha-tocophéryle | Vitamine E | 300 mg | 30 mg |
Additives
E463, E470b, E460
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Ce complément alimentaire doit être utilisé dans le cadre d'un mode de vie sain et ne pas être utilisé comme substitut d'un régime alimentaire varié et équilibré. Ne pas dépasser la dose journalière recommandée. Tenir hors de la portée des jeunes enfants. Réservé aux adultes. Déconseillé aux femmes enceintes ou allaitantes. (vigne rouge)
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Euterpe oleracea Mart.
Read the warning, when it applies and the studies cited
ACAI – EUTERPE OLERACEA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (derMarderosian and Beutler 2008).
Sources cited by Health Canada (1)
- derMarderosian A, Beutler JA, editors. The Review of Natural Products. [Acai: Date of issue January 2008]. St Louis (MO): Facts and Comparisons, Wolters Kluwer Health; Printed in 2008 and Updated to April 2012.
Known adverse reactions
Stop use if hypersensitivity/allergy occurs (derMarderosian and Beutler 2008).
Sources cited by Health Canada (1)
- derMarderosian A, Beutler JA, editors. The Review of Natural Products. [Acai: Date of issue January 2008]. St Louis (MO): Facts and Comparisons, Wolters Kluwer Health; Printed in 2008 and Updated to April 2012.
- Vaccinium myrtillus L.
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
- Punica granatum L.
Read the warning, when it applies and the studies cited
- Ubiquinone
Read the warning, when it applies and the studies cited
Coenzyme Q10 (UBIQUINONE-10)
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood pressure medication (Rosenfeldt et al. 2007; Singh et al. 1999).
Sources cited by Health Canada (2)
- Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. Journal of Human Hypertension 2007;21(4):297-306. PubMed Meta-analysis
- Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. Journal of Human Hypertension 1999;13(3):203-208. PubMed Randomised trial
Applies to products providing more than 100 mg of Coenzyme Q10 per day.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Engelsen et al. 2003; Landbo and Almdal 1998; Spigset 1994).
Sources cited by Health Canada (3)
- Engelsen J, Nielsen JD, Hansen KF. [Effect of coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger 2003;165(18):1868-1871 (in Danish). PubMed Randomised trial
- Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger 1998;160(22):3226-3227 (in Danish). PubMed Case report
- Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet 1994;344(8933):1372-1373. PubMed Case report
Condition of application: Migraine prophylaxis/prevention.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if migraine frequency increases and associated nausea and vomiting persist or worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- COLLAGENE + ETERNITY GRANIONS, declared in 2025 : different composition: 12 ingredient(s) added, 27 missing
Brand : GRANIONS
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.